Century Therapeutics (IPSC) Revenue (2022 - 2025)
Century Therapeutics (IPSC) posted quarterly Revenue of $109.2 million for Q1 2025, up 12667.72% year-over-year from N/an in Q1 2024, and up 2515.96% quarter-over-quarter from $4.2 million in Q4 2024.
Century Therapeutics (IPSC) Revenue (2022 - 2025) Analysis & Trends
Century Therapeutics (IPSC) has reported Revenue for 4 consecutive years, with $109.2 million the latest figure, recorded in Q1 2025.
- In Q1 2025, Revenue rose 12667.72% year-over-year to $109.2 million; the TTM figure through Dec 2025 stood at $109.2 million (up 1556.51% YoY), while the FY2025 annual figure was $109.2 million, up 1556.76% from the prior year.
- Revenue climbed to $109.2 million in Q1 2025 per IPSC's latest filing, from $4.2 million in the prior quarter.
- Across five years, Revenue topped out at $109.2 million in Q1 2025 and bottomed at $99000.0 in Q2 2023.
- Historically, Revenue has averaged $9.5 million across 4 years, with a median of $855000.0 in 2024.
- Annual changes were most pronounced in 2023 — Revenue plunged 93.35% — and 2025, when it soared 12667.72%.
- Century Therapeutics' Revenue stood at $521000.0 in 2022, then plunged by 48.56% to $268000.0 in 2023, then surged by 1457.09% to $4.2 million in 2024, then soared by 2515.96% to $109.2 million in 2025.
- Business Quant data shows IPSC's Revenue at $109.2 million in Q1 2025, $4.2 million in Q4 2024, and $791000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Century Therapeutics | 346.65 Mn | 86.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 109.16 Mn |
| Dec 31, 2024 | 4.17 Mn |
| Sep 30, 2024 | 791,000.00 |
| Jun 30, 2024 | 771,000.00 |
| Mar 31, 2024 | 855,000.00 |
| Dec 31, 2023 | 268,000.00 |
| Sep 30, 2023 | 148,000.00 |
| Jun 30, 2023 | 99,000.00 |
| Mar 31, 2023 | 1.72 Mn |
| Dec 31, 2022 | 521,000.00 |
| Sep 30, 2022 | 2.22 Mn |
| Jun 30, 2022 | 1.40 Mn |
| Mar 31, 2022 | 1.06 Mn |